These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34985284)

  • 1. Tandem Mass Spectrometry Molecular Networking as a Powerful and Efficient Tool for Drug Metabolism Studies.
    Yu JS; Nothias LF; Wang M; Kim DH; Dorrestein PC; Kang KB; Yoo HH
    Anal Chem; 2022 Jan; 94(2):1456-1464. PubMed ID: 34985284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy of using microsome-based metabolite production to facilitate the identification of endogenous metabolites by liquid chromatography mass spectrometry.
    Clements M; Li L
    Anal Chim Acta; 2011 Jan; 685(1):36-44. PubMed ID: 21168549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-targeted metabolomics-guided sildenafil metabolism study in human liver microsomes.
    Kim JH; Jo JH; Seo KA; Hwang H; Lee HS; Lee S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1072():86-93. PubMed ID: 29136555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feature-Based Molecular Networking for Metabolite Annotation.
    Phelan VV
    Methods Mol Biol; 2020; 2104():227-243. PubMed ID: 31953821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Untargeted metabolomics by high resolution mass spectrometry coupled to normal and reversed phase liquid chromatography as a tool to study the in vitro biotransformation of new psychoactive substances.
    Manier SK; Keller A; Schäper J; Meyer MR
    Sci Rep; 2019 Feb; 9(1):2741. PubMed ID: 30808896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of peak-picking workflows for untargeted liquid chromatography/high-resolution mass spectrometry metabolomics data analysis.
    Rafiei A; Sleno L
    Rapid Commun Mass Spectrom; 2015 Jan; 29(1):119-27. PubMed ID: 25462372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized experimental workflow for tandem mass spectrometry molecular networking in metabolomics.
    Olivon F; Roussi F; Litaudon M; Touboul D
    Anal Bioanal Chem; 2017 Sep; 409(24):5767-5778. PubMed ID: 28762069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrieving and Utilizing Hypothetical Neutral Losses from Tandem Mass Spectra for Spectral Similarity Analysis and Unknown Metabolite Annotation.
    Xing S; Hu Y; Yin Z; Liu M; Tang X; Fang M; Huan T
    Anal Chem; 2020 Nov; 92(21):14476-14483. PubMed ID: 33076659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated strategy to improve data acquisition and metabolite identification by time-staggered ion lists in UHPLC/Q-TOF MS-based metabolomics.
    Wang Y; Feng R; He C; Su H; Ma H; Wan JB
    J Pharm Biomed Anal; 2018 Aug; 157():171-179. PubMed ID: 29802989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METLIN: A Tandem Mass Spectral Library of Standards.
    Montenegro-Burke JR; Guijas C; Siuzdak G
    Methods Mol Biol; 2020; 2104():149-163. PubMed ID: 31953817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A New Workflow for Drug Metabolite Profiling by Utilizing Advanced Tribrid Mass Spectrometry and Data-Processing Techniques.
    Ruan Q; Comstock K
    J Am Soc Mass Spectrom; 2021 Aug; 32(8):2050-2061. PubMed ID: 33998806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of Molecular Networking and In-Silico MS/MS Fragmentation for Natural Products Dereplication.
    Allard PM; Péresse T; Bisson J; Gindro K; Marcourt L; Pham VC; Roussi F; Litaudon M; Wolfender JL
    Anal Chem; 2016 Mar; 88(6):3317-23. PubMed ID: 26882108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of Tandem Mass Spectral and Metabolite Databases for Metabolite Identification in Metabolomics.
    Yi Z; Zhu ZJ
    Methods Mol Biol; 2020; 2104():139-148. PubMed ID: 31953816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stable isotope labeling strategy for curcumin metabolite study in human liver microsomes by liquid chromatography-tandem mass spectrometry.
    Gao D; Chen X; Yang X; Wu Q; Jin F; Wen H; Jiang Y; Liu H
    J Am Soc Mass Spectrom; 2015 Apr; 26(4):686-94. PubMed ID: 25592681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolite identification for mass spectrometry-based metabolomics using multiple types of correlated ion information.
    Lynn KS; Cheng ML; Chen YR; Hsu C; Chen A; Lih TM; Chang HY; Huang CJ; Shiao MS; Pan WH; Sung TY; Hsu WL
    Anal Chem; 2015 Feb; 87(4):2143-51. PubMed ID: 25543920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing untargeted metabolomics using data-independent acquisition mass spectrometry technology.
    Wang R; Yin Y; Zhu ZJ
    Anal Bioanal Chem; 2019 Jul; 411(19):4349-4357. PubMed ID: 30847570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Liquid Chromatography-Mass Spectrometry-Based Metabolomics to Identify Biomarkers of Tuberculosis.
    Zhou J; Yin Y
    Methods Mol Biol; 2019; 1859():241-251. PubMed ID: 30421233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The application of high-resolution mass spectrometry-based data-mining tools in tandem to metabolite profiling of a triple drug combination in humans.
    Xing J; Zang M; Zhang H; Zhu M
    Anal Chim Acta; 2015 Oct; 897():34-44. PubMed ID: 26515003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy combining solid-phase extraction, multiple mass defect filtering and molecular networking for rapid structural classification and annotation of natural products: characterization of chemical diversity in Citrus aurantium as a case study.
    Wang YK; Xiao XR; Zhou ZM; Xiao Y; Zhu WF; Liu HN; Li F
    Anal Bioanal Chem; 2021 May; 413(11):2879-2891. PubMed ID: 33822260
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.